As a member of the Coverage & Pricing team, the Senior Marketing Manager, Tezepelumab Launch, reports to the Director of Portfolio Coverage & Pricing with a dotted line to the Director, Tezepelumab Launch. Partnering with the tezepelumab brand team and AstraZeneca counterparts, this role supports development of and executes payer strategy for the Market Access and sales teams to ensure efficient launch payer coverage and patient access to tezepelumab.
This role will further develop a foundation in the U.S. healthcare market and is a good avenue to many future commercial healthcare roles. Amgen has strong training, education, and mentoring programs to ensure staff are successful.
5-10% travel may be required.
Job duties will include:
Support development and delivery of tezepelumab launch strategy (strategy developed with launch Director, AstraZeneca and brand team), using quantitative modeling
Work on the creation and implementation of value-based contracts in collaboration with Global Health Economics, Legal, and Strategic Pricing & Contracting teams
Development of the latest estimate discount rate model and process for tezepelumab
Coordinate with Trade Operations to evaluate and handle specialty pharmacy fee-for-service data and reporting opportunities, as appropriate
Lead planning and logistics for launch lead-sponsored workshops
Lead all aspects of Market Access launch coverage/POA goals and support dashboard activities
Point of contact for the Market Access team and tezepelumab sales force, including communication of substantial payer coverage to the sales force and “pull-through” delivery at launch.
Collaborate with Patient Access team, Launch Lead and brand team to develop/launch patient support programs and manage adjustments in real-time as the payer environment evolves
Collaborate with value marketing function to build value strategy, messaging, tools for Market Access and data generation plan in alignment with brand strategy. This includes developing payer clinical messaging, pharmacoeconomic messaging and population health and employer-specific tools for Market Access, as needed.
Conduct periodic tezepelumab (V&A) launch team meetings (usually monthly) to communicate strategy and to drive alignment.
Coordinate with the Value Marketing and training teams to develop Market Access semester plan of action, semester meeting content/training and reimbursement goals, and provide tezepelumab-related training as appropriate.
Assist with planning and quarterly business reviews and long-range scenario planning
Triage payer-related questions and issues and ensure that items are quickly addressed for the sales and Market Access teams.
Lead tezepelumab payer-related budget management.
MBA or other Master’s degree
Strong eye for business, analytical skills, and critical thinking ability
Understanding of US health care system and key partners (with an interest in formulary decision makers carrying out responsibilities for the selection of medications for coverage or reimbursement)
Marketing or sales experience, specifically in immunology (asthma focus)
Payer or value marketing experience, especially in highly driven market environments
Outstanding written and verbal communication and presentation skills
Project management skills and cross-functional leadership. Ability to work through others and lead in a matrix environment, along with achieving results with multiple contending priorities.
Vendor/agency management skills
Internal Number: R-97872
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.